Pyxis Biologix
Research Stage
Proprietary Delivery
USA Made
Pyxis Biologix develops delivery systems that change how active compounds reach the body, focusing on transdermal and liposomal formats.
The work addresses a constraint that affects the whole portfolio: a compound is only as useful as its ability to be absorbed. Programmes developed here can move into group manufacturing once they are ready.
Capabilities
- Transdermal delivery system development
- Liposomal encapsulation research
- Absorption and bioavailability programmes
- Formulation work for portfolio brands
Position in the chain
01
Research
02
Manufacture
03
Test
04
Compound
05
Prescribe
06
Fulfill
07
Educate
%201.svg){kind=logo}